Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation.
about
Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation.Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationRandomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical triSevere interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature.Pairwise protein expression classifier for candidate biomarker discovery for early detection of human disease prognosis.Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantationIncreased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Management of infectious complications in the hematopoietic stem cell transplant recipient.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesPulmonary complications of solid organ and hematopoietic stem cell transplantation.Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation.Evaluation of pulmonary infiltrates in patients after stem cell transplantation.A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.Anesthesia and graft-vs-host disease after hematopoietic stem cell transplantation.Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.Pulmonary complications after hematopoietic stem cell transplantation.Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics.Imaging of complications from hematopoietic stem cell transplantLate-onset noninfectious interstitial lung disease following autologous haematopoietic stem cell transplantation in paediatric patients.Blood transfusions and pulmonary complications after hematopoietic cell transplantation.Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation.Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children.Pneumocystis carinii infection sensitizes lung to radiation-induced injury after syngeneic marrow transplantation: role of CD4+ T cells.Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children.Pre-operative and post-operative spirometry in bone marrow transplant patients.Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT.Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant.Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.Respiratory failure in the hematopoietic stem cell transplant recipient
P2860
Q30253063-D98CA159-5446-4409-BB92-73808E1D6BEEQ32052931-1C03E9D8-613E-4088-A273-CA600A147F4CQ33645826-AB3261D9-9178-4EBC-9559-D5A90099466AQ33760834-99E7B47E-7ADC-4B4D-A03A-C174A7570601Q34027424-E2A1B2AF-39F4-476B-85B0-E8C9F90C7F03Q34225862-008EF071-0127-4374-9EC3-FE1DF53775FEQ34369852-CEFF3B8F-9FB0-4828-A808-968E7950F7CBQ34396430-F25381DD-1E72-44D6-BB6C-CB2F66D09934Q34607576-CE4275B0-341F-4FCF-9EC8-1469727F0E8EQ34858453-509B7383-2052-431B-B3B3-839AEF951BD1Q35534299-5323046E-FD15-4E8D-87F1-D41383EE23C9Q35594089-015A8B9E-C752-4863-AC0A-365B1200DDE4Q35675979-2267AC9E-367C-4FC4-8002-A2AC2057AA37Q35694784-CE12FC23-98D2-4266-B9C9-91CA9895FF45Q35724040-BE549EFF-A329-408D-935D-B27EE42CE9F6Q35740698-F0545AE2-A82C-49D4-98DA-80A53B7EBC04Q35745142-FF7BAF44-5AA1-4103-BA13-497521D919DEQ35852267-5ECE0589-D6F7-4372-9153-3EB9C876D181Q35858408-3BA0C74C-F006-4D6E-B096-CF2967943225Q36209078-3B9F61E5-B0C8-4F7B-83A6-622C9EFA4A8AQ36328397-F297D02B-CF77-4F7E-98B9-44961C7E5B2CQ36665735-808B284D-9E48-400C-8793-BAA84FACCFC8Q36690346-BB364C75-4F02-4020-80F4-8B54D655F0BBQ37100510-68928481-911A-4E54-8388-9C52525C4FBFQ37313313-2EA02B61-2DFB-4E87-B11D-A142AA6741C0Q37629920-06AAB3E2-4C8E-46E2-9E76-F8E3CE0121BEQ38285644-F5078FE1-9C71-4F2D-9C6D-79AF8CBAED1DQ39855262-8773A4B6-0CDB-4E79-8E90-E46F83E71221Q40243803-45D3605C-B61B-4E01-AAB9-D241A20B02C6Q43591859-030800F3-444C-4E3B-B2B0-A8918C896047Q44049737-58A1B473-03AE-4A75-9483-0716703D2E78Q44828700-0A5601D3-B0E3-42E3-B35A-122DC92BA091Q45799176-D2C42FF7-7EDF-427B-B9EA-BCA0C24F5AD7Q47658527-6977C671-9E72-4701-92F6-8FB3B09922FCQ51008175-DA4665DE-B286-4571-BDC7-40C75C1E4AC3Q51750231-EE233E0F-343F-48E0-84C7-1D16FDE6D754Q51779327-E0873254-731E-44D6-9C65-717B13EF0091Q53774182-6AF0DC36-3A95-40D4-9A78-44E3A18BE0B3Q54253594-BC47B362-12D9-4AB6-A6AF-6AF5ADED7CC9Q58121933-37FF2D9F-E904-4DD4-B085-FBCD9BB20E05
P2860
Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Idiopathic pneumonia syndrome: ...... after marrow transplantation.
@en
type
label
Idiopathic pneumonia syndrome: ...... after marrow transplantation.
@en
prefLabel
Idiopathic pneumonia syndrome: ...... after marrow transplantation.
@en
P2093
P1433
P1476
Idiopathic pneumonia syndrome: ...... after marrow transplantation.
@en
P2093
R C Hackman
S P Kantrow
S W Crawford
P304
P356
10.1097/00007890-199704270-00006
P577
1997-04-01T00:00:00Z